These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 9428473

  • 1. Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats.
    Park YS, Guijarro C, Kim Y, Massy ZA, Kasiske BL, Keane WF, O'Donnell MP.
    Am J Kidney Dis; 1998 Jan; 31(1):190-4. PubMed ID: 9428473
    [Abstract] [Full Text] [Related]

  • 2. Cholesterol, macrophages, and gene expression of TGF-beta 1 and fibronectin during nephrosis.
    Ding G, Pesek-Diamond I, Diamond JR.
    Am J Physiol; 1993 Apr; 264(4 Pt 2):F577-84. PubMed ID: 8476071
    [Abstract] [Full Text] [Related]

  • 3. Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin.
    Kim SY, Guijarro C, O'Donnell MP, Kasiske BL, Kim Y, Keane WF.
    Kidney Int; 1995 Aug; 48(2):363-71. PubMed ID: 7564103
    [Abstract] [Full Text] [Related]

  • 4. Glomerular macrophages and the mesangial proliferative response in the experimental nephrotic syndrome.
    Diamond JR, Ding G, Frye J, Diamond IP.
    Am J Pathol; 1992 Oct; 141(4):887-94. PubMed ID: 1415482
    [Abstract] [Full Text] [Related]

  • 5. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
    Diamond JR, Pesek I.
    Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of progression of chronic puromycin aminonucleoside nephrosis by probucol, an antioxidant.
    Magil A.
    J Am Soc Nephrol; 1996 Nov; 7(11):2340-7. PubMed ID: 8959623
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM, Chien CT, Hu-Tsai MI, Wu KD, Tsai CC, Wu MS, Tsai TJ.
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [Abstract] [Full Text] [Related]

  • 12. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
    Ebihara I, Nakamura T, Tomino Y, Koide H.
    Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
    [Abstract] [Full Text] [Related]

  • 13. Failure of antioxidant therapy to attenuate interstitial disease in rats with reversible nephrotic syndrome.
    Drukker A, Eddy AA.
    J Am Soc Nephrol; 1998 Feb; 9(2):243-51. PubMed ID: 9527400
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis.
    Fernandez L, Romero M, Rincón J, Mosquera J.
    Nephron Exp Nephrol; 2003 Feb; 94(2):e55-65. PubMed ID: 12845231
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.